- Advisers to the U.S Food and Drug Administration on Thursday voted against recommending Spectrum Pharmaceuticals' experimental drug to treat patients with a form of non-small cell lung cancer.
(Reporting by Khushi Mandowara and Mrinalika Roy; Editing by Shailesh Kuber)